Global Immune Cell Therapy Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Immune Cell Therapy Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Immune Cell Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immune Cell Therapy Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immune Cell Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immune Cell Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immune Cell Therapy Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Cell Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Cell Therapy Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aquila BioMedical, BPS Bioscience, Celentyx, Crown Bioscience and DiscoverX Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Immune Cell Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Immune Cell Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immune Cell Therapy Drugs, with revenue, gross margin and global market share of Immune Cell Therapy Drugs from 2018 to 2023.
Chapter 3, the Immune Cell Therapy Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immune Cell Therapy Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Cell Therapy Drugs.
Chapter 13, to describe Immune Cell Therapy Drugs research findings and conclusion.
This report is a detailed and comprehensive analysis for global Immune Cell Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immune Cell Therapy Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immune Cell Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immune Cell Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immune Cell Therapy Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Cell Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Cell Therapy Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aquila BioMedical, BPS Bioscience, Celentyx, Crown Bioscience and DiscoverX Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Immune Cell Therapy Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal Antibodies
- Immunomodulator
- Other
- Stomach Cancer
- lung Cancer
- Colorectal Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Other
- Aquila BioMedical
- BPS Bioscience
- Celentyx
- Crown Bioscience
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences
- Horizon Discovery Group
- ImmunXperts
- Molecular Imaging
- Promega Corporation,Personalis
- STC Biologics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Immune Cell Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immune Cell Therapy Drugs, with revenue, gross margin and global market share of Immune Cell Therapy Drugs from 2018 to 2023.
Chapter 3, the Immune Cell Therapy Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immune Cell Therapy Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Cell Therapy Drugs.
Chapter 13, to describe Immune Cell Therapy Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immune Cell Therapy Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immune Cell Therapy Drugs by Type
1.3.1 Overview: Global Immune Cell Therapy Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Immune Cell Therapy Drugs Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Immunomodulator
1.3.5 Other
1.4 Global Immune Cell Therapy Drugs Market by Application
1.4.1 Overview: Global Immune Cell Therapy Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Stomach Cancer
1.4.3 lung Cancer
1.4.4 Colorectal Cancer
1.4.5 Esophageal Cancer
1.4.6 Pancreatic Cancer
1.4.7 Other
1.5 Global Immune Cell Therapy Drugs Market Size & Forecast
1.6 Global Immune Cell Therapy Drugs Market Size and Forecast by Region
1.6.1 Global Immune Cell Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Immune Cell Therapy Drugs Market Size by Region, (2018-2029)
1.6.3 North America Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Aquila BioMedical
2.1.1 Aquila BioMedical Details
2.1.2 Aquila BioMedical Major Business
2.1.3 Aquila BioMedical Immune Cell Therapy Drugs Product and Solutions
2.1.4 Aquila BioMedical Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aquila BioMedical Recent Developments and Future Plans
2.2 BPS Bioscience
2.2.1 BPS Bioscience Details
2.2.2 BPS Bioscience Major Business
2.2.3 BPS Bioscience Immune Cell Therapy Drugs Product and Solutions
2.2.4 BPS Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BPS Bioscience Recent Developments and Future Plans
2.3 Celentyx
2.3.1 Celentyx Details
2.3.2 Celentyx Major Business
2.3.3 Celentyx Immune Cell Therapy Drugs Product and Solutions
2.3.4 Celentyx Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Celentyx Recent Developments and Future Plans
2.4 Crown Bioscience
2.4.1 Crown Bioscience Details
2.4.2 Crown Bioscience Major Business
2.4.3 Crown Bioscience Immune Cell Therapy Drugs Product and Solutions
2.4.4 Crown Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Crown Bioscience Recent Developments and Future Plans
2.5 DiscoverX Corporation
2.5.1 DiscoverX Corporation Details
2.5.2 DiscoverX Corporation Major Business
2.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Product and Solutions
2.5.4 DiscoverX Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DiscoverX Corporation Recent Developments and Future Plans
2.6 Explicyte
2.6.1 Explicyte Details
2.6.2 Explicyte Major Business
2.6.3 Explicyte Immune Cell Therapy Drugs Product and Solutions
2.6.4 Explicyte Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Explicyte Recent Developments and Future Plans
2.7 Genscript Biotech Corporation
2.7.1 Genscript Biotech Corporation Details
2.7.2 Genscript Biotech Corporation Major Business
2.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Product and Solutions
2.7.4 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Genscript Biotech Corporation Recent Developments and Future Plans
2.8 HD Biosciences
2.8.1 HD Biosciences Details
2.8.2 HD Biosciences Major Business
2.8.3 HD Biosciences Immune Cell Therapy Drugs Product and Solutions
2.8.4 HD Biosciences Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 HD Biosciences Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Product and Solutions
2.9.4 Horizon Discovery Group Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 ImmunXperts
2.10.1 ImmunXperts Details
2.10.2 ImmunXperts Major Business
2.10.3 ImmunXperts Immune Cell Therapy Drugs Product and Solutions
2.10.4 ImmunXperts Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ImmunXperts Recent Developments and Future Plans
2.11 Molecular Imaging
2.11.1 Molecular Imaging Details
2.11.2 Molecular Imaging Major Business
2.11.3 Molecular Imaging Immune Cell Therapy Drugs Product and Solutions
2.11.4 Molecular Imaging Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Molecular Imaging Recent Developments and Future Plans
2.12 Promega Corporation,Personalis
2.12.1 Promega Corporation,Personalis Details
2.12.2 Promega Corporation,Personalis Major Business
2.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Product and Solutions
2.12.4 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Promega Corporation,Personalis Recent Developments and Future Plans
2.13 STC Biologics
2.13.1 STC Biologics Details
2.13.2 STC Biologics Major Business
2.13.3 STC Biologics Immune Cell Therapy Drugs Product and Solutions
2.13.4 STC Biologics Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 STC Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immune Cell Therapy Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Immune Cell Therapy Drugs by Company Revenue
3.2.2 Top 3 Immune Cell Therapy Drugs Players Market Share in 2022
3.2.3 Top 6 Immune Cell Therapy Drugs Players Market Share in 2022
3.3 Immune Cell Therapy Drugs Market: Overall Company Footprint Analysis
3.3.1 Immune Cell Therapy Drugs Market: Region Footprint
3.3.2 Immune Cell Therapy Drugs Market: Company Product Type Footprint
3.3.3 Immune Cell Therapy Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immune Cell Therapy Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Immune Cell Therapy Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Immune Cell Therapy Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
6.2 North America Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
6.3 North America Immune Cell Therapy Drugs Market Size by Country
6.3.1 North America Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
7.2 Europe Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
7.3 Europe Immune Cell Therapy Drugs Market Size by Country
7.3.1 Europe Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.3 France Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region
8.3.1 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2018-2029)
8.3.2 China Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.5 India Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
9.2 South America Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
9.3 South America Immune Cell Therapy Drugs Market Size by Country
9.3.1 South America Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country
10.3.1 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Immune Cell Therapy Drugs Market Drivers
11.2 Immune Cell Therapy Drugs Market Restraints
11.3 Immune Cell Therapy Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Immune Cell Therapy Drugs Industry Chain
12.2 Immune Cell Therapy Drugs Upstream Analysis
12.3 Immune Cell Therapy Drugs Midstream Analysis
12.4 Immune Cell Therapy Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Immune Cell Therapy Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immune Cell Therapy Drugs by Type
1.3.1 Overview: Global Immune Cell Therapy Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Immune Cell Therapy Drugs Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Immunomodulator
1.3.5 Other
1.4 Global Immune Cell Therapy Drugs Market by Application
1.4.1 Overview: Global Immune Cell Therapy Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Stomach Cancer
1.4.3 lung Cancer
1.4.4 Colorectal Cancer
1.4.5 Esophageal Cancer
1.4.6 Pancreatic Cancer
1.4.7 Other
1.5 Global Immune Cell Therapy Drugs Market Size & Forecast
1.6 Global Immune Cell Therapy Drugs Market Size and Forecast by Region
1.6.1 Global Immune Cell Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Immune Cell Therapy Drugs Market Size by Region, (2018-2029)
1.6.3 North America Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Immune Cell Therapy Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Aquila BioMedical
2.1.1 Aquila BioMedical Details
2.1.2 Aquila BioMedical Major Business
2.1.3 Aquila BioMedical Immune Cell Therapy Drugs Product and Solutions
2.1.4 Aquila BioMedical Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aquila BioMedical Recent Developments and Future Plans
2.2 BPS Bioscience
2.2.1 BPS Bioscience Details
2.2.2 BPS Bioscience Major Business
2.2.3 BPS Bioscience Immune Cell Therapy Drugs Product and Solutions
2.2.4 BPS Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BPS Bioscience Recent Developments and Future Plans
2.3 Celentyx
2.3.1 Celentyx Details
2.3.2 Celentyx Major Business
2.3.3 Celentyx Immune Cell Therapy Drugs Product and Solutions
2.3.4 Celentyx Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Celentyx Recent Developments and Future Plans
2.4 Crown Bioscience
2.4.1 Crown Bioscience Details
2.4.2 Crown Bioscience Major Business
2.4.3 Crown Bioscience Immune Cell Therapy Drugs Product and Solutions
2.4.4 Crown Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Crown Bioscience Recent Developments and Future Plans
2.5 DiscoverX Corporation
2.5.1 DiscoverX Corporation Details
2.5.2 DiscoverX Corporation Major Business
2.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Product and Solutions
2.5.4 DiscoverX Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DiscoverX Corporation Recent Developments and Future Plans
2.6 Explicyte
2.6.1 Explicyte Details
2.6.2 Explicyte Major Business
2.6.3 Explicyte Immune Cell Therapy Drugs Product and Solutions
2.6.4 Explicyte Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Explicyte Recent Developments and Future Plans
2.7 Genscript Biotech Corporation
2.7.1 Genscript Biotech Corporation Details
2.7.2 Genscript Biotech Corporation Major Business
2.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Product and Solutions
2.7.4 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Genscript Biotech Corporation Recent Developments and Future Plans
2.8 HD Biosciences
2.8.1 HD Biosciences Details
2.8.2 HD Biosciences Major Business
2.8.3 HD Biosciences Immune Cell Therapy Drugs Product and Solutions
2.8.4 HD Biosciences Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 HD Biosciences Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Product and Solutions
2.9.4 Horizon Discovery Group Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 ImmunXperts
2.10.1 ImmunXperts Details
2.10.2 ImmunXperts Major Business
2.10.3 ImmunXperts Immune Cell Therapy Drugs Product and Solutions
2.10.4 ImmunXperts Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ImmunXperts Recent Developments and Future Plans
2.11 Molecular Imaging
2.11.1 Molecular Imaging Details
2.11.2 Molecular Imaging Major Business
2.11.3 Molecular Imaging Immune Cell Therapy Drugs Product and Solutions
2.11.4 Molecular Imaging Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Molecular Imaging Recent Developments and Future Plans
2.12 Promega Corporation,Personalis
2.12.1 Promega Corporation,Personalis Details
2.12.2 Promega Corporation,Personalis Major Business
2.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Product and Solutions
2.12.4 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Promega Corporation,Personalis Recent Developments and Future Plans
2.13 STC Biologics
2.13.1 STC Biologics Details
2.13.2 STC Biologics Major Business
2.13.3 STC Biologics Immune Cell Therapy Drugs Product and Solutions
2.13.4 STC Biologics Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 STC Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immune Cell Therapy Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Immune Cell Therapy Drugs by Company Revenue
3.2.2 Top 3 Immune Cell Therapy Drugs Players Market Share in 2022
3.2.3 Top 6 Immune Cell Therapy Drugs Players Market Share in 2022
3.3 Immune Cell Therapy Drugs Market: Overall Company Footprint Analysis
3.3.1 Immune Cell Therapy Drugs Market: Region Footprint
3.3.2 Immune Cell Therapy Drugs Market: Company Product Type Footprint
3.3.3 Immune Cell Therapy Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immune Cell Therapy Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Immune Cell Therapy Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Immune Cell Therapy Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
6.2 North America Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
6.3 North America Immune Cell Therapy Drugs Market Size by Country
6.3.1 North America Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
7.2 Europe Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
7.3 Europe Immune Cell Therapy Drugs Market Size by Country
7.3.1 Europe Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.3 France Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region
8.3.1 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2018-2029)
8.3.2 China Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.5 India Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
9.2 South America Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
9.3 South America Immune Cell Therapy Drugs Market Size by Country
9.3.1 South America Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country
10.3.1 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Immune Cell Therapy Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Immune Cell Therapy Drugs Market Drivers
11.2 Immune Cell Therapy Drugs Market Restraints
11.3 Immune Cell Therapy Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Immune Cell Therapy Drugs Industry Chain
12.2 Immune Cell Therapy Drugs Upstream Analysis
12.3 Immune Cell Therapy Drugs Midstream Analysis
12.4 Immune Cell Therapy Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Immune Cell Therapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immune Cell Therapy Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Immune Cell Therapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Immune Cell Therapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Aquila BioMedical Company Information, Head Office, and Major Competitors
Table 6. Aquila BioMedical Major Business
Table 7. Aquila BioMedical Immune Cell Therapy Drugs Product and Solutions
Table 8. Aquila BioMedical Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Aquila BioMedical Recent Developments and Future Plans
Table 10. BPS Bioscience Company Information, Head Office, and Major Competitors
Table 11. BPS Bioscience Major Business
Table 12. BPS Bioscience Immune Cell Therapy Drugs Product and Solutions
Table 13. BPS Bioscience Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BPS Bioscience Recent Developments and Future Plans
Table 15. Celentyx Company Information, Head Office, and Major Competitors
Table 16. Celentyx Major Business
Table 17. Celentyx Immune Cell Therapy Drugs Product and Solutions
Table 18. Celentyx Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Celentyx Recent Developments and Future Plans
Table 20. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 21. Crown Bioscience Major Business
Table 22. Crown Bioscience Immune Cell Therapy Drugs Product and Solutions
Table 23. Crown Bioscience Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Crown Bioscience Recent Developments and Future Plans
Table 25. DiscoverX Corporation Company Information, Head Office, and Major Competitors
Table 26. DiscoverX Corporation Major Business
Table 27. DiscoverX Corporation Immune Cell Therapy Drugs Product and Solutions
Table 28. DiscoverX Corporation Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. DiscoverX Corporation Recent Developments and Future Plans
Table 30. Explicyte Company Information, Head Office, and Major Competitors
Table 31. Explicyte Major Business
Table 32. Explicyte Immune Cell Therapy Drugs Product and Solutions
Table 33. Explicyte Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Explicyte Recent Developments and Future Plans
Table 35. Genscript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 36. Genscript Biotech Corporation Major Business
Table 37. Genscript Biotech Corporation Immune Cell Therapy Drugs Product and Solutions
Table 38. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Genscript Biotech Corporation Recent Developments and Future Plans
Table 40. HD Biosciences Company Information, Head Office, and Major Competitors
Table 41. HD Biosciences Major Business
Table 42. HD Biosciences Immune Cell Therapy Drugs Product and Solutions
Table 43. HD Biosciences Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. HD Biosciences Recent Developments and Future Plans
Table 45. Horizon Discovery Group Company Information, Head Office, and Major Competitors
Table 46. Horizon Discovery Group Major Business
Table 47. Horizon Discovery Group Immune Cell Therapy Drugs Product and Solutions
Table 48. Horizon Discovery Group Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Horizon Discovery Group Recent Developments and Future Plans
Table 50. ImmunXperts Company Information, Head Office, and Major Competitors
Table 51. ImmunXperts Major Business
Table 52. ImmunXperts Immune Cell Therapy Drugs Product and Solutions
Table 53. ImmunXperts Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ImmunXperts Recent Developments and Future Plans
Table 55. Molecular Imaging Company Information, Head Office, and Major Competitors
Table 56. Molecular Imaging Major Business
Table 57. Molecular Imaging Immune Cell Therapy Drugs Product and Solutions
Table 58. Molecular Imaging Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Molecular Imaging Recent Developments and Future Plans
Table 60. Promega Corporation,Personalis Company Information, Head Office, and Major Competitors
Table 61. Promega Corporation,Personalis Major Business
Table 62. Promega Corporation,Personalis Immune Cell Therapy Drugs Product and Solutions
Table 63. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Promega Corporation,Personalis Recent Developments and Future Plans
Table 65. STC Biologics Company Information, Head Office, and Major Competitors
Table 66. STC Biologics Major Business
Table 67. STC Biologics Immune Cell Therapy Drugs Product and Solutions
Table 68. STC Biologics Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. STC Biologics Recent Developments and Future Plans
Table 70. Global Immune Cell Therapy Drugs Revenue (USD Million) by Players (2018-2023)
Table 71. Global Immune Cell Therapy Drugs Revenue Share by Players (2018-2023)
Table 72. Breakdown of Immune Cell Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Immune Cell Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Immune Cell Therapy Drugs Players
Table 75. Immune Cell Therapy Drugs Market: Company Product Type Footprint
Table 76. Immune Cell Therapy Drugs Market: Company Product Application Footprint
Table 77. Immune Cell Therapy Drugs New Market Entrants and Barriers to Market Entry
Table 78. Immune Cell Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Immune Cell Therapy Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Immune Cell Therapy Drugs Consumption Value Share by Type (2018-2023)
Table 81. Global Immune Cell Therapy Drugs Consumption Value Forecast by Type (2024-2029)
Table 82. Global Immune Cell Therapy Drugs Consumption Value by Application (2018-2023)
Table 83. Global Immune Cell Therapy Drugs Consumption Value Forecast by Application (2024-2029)
Table 84. North America Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Immune Cell Therapy Drugs Raw Material
Table 115. Key Suppliers of Immune Cell Therapy Drugs Raw Materials
Table 1. Global Immune Cell Therapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immune Cell Therapy Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Immune Cell Therapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Immune Cell Therapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Aquila BioMedical Company Information, Head Office, and Major Competitors
Table 6. Aquila BioMedical Major Business
Table 7. Aquila BioMedical Immune Cell Therapy Drugs Product and Solutions
Table 8. Aquila BioMedical Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Aquila BioMedical Recent Developments and Future Plans
Table 10. BPS Bioscience Company Information, Head Office, and Major Competitors
Table 11. BPS Bioscience Major Business
Table 12. BPS Bioscience Immune Cell Therapy Drugs Product and Solutions
Table 13. BPS Bioscience Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BPS Bioscience Recent Developments and Future Plans
Table 15. Celentyx Company Information, Head Office, and Major Competitors
Table 16. Celentyx Major Business
Table 17. Celentyx Immune Cell Therapy Drugs Product and Solutions
Table 18. Celentyx Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Celentyx Recent Developments and Future Plans
Table 20. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 21. Crown Bioscience Major Business
Table 22. Crown Bioscience Immune Cell Therapy Drugs Product and Solutions
Table 23. Crown Bioscience Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Crown Bioscience Recent Developments and Future Plans
Table 25. DiscoverX Corporation Company Information, Head Office, and Major Competitors
Table 26. DiscoverX Corporation Major Business
Table 27. DiscoverX Corporation Immune Cell Therapy Drugs Product and Solutions
Table 28. DiscoverX Corporation Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. DiscoverX Corporation Recent Developments and Future Plans
Table 30. Explicyte Company Information, Head Office, and Major Competitors
Table 31. Explicyte Major Business
Table 32. Explicyte Immune Cell Therapy Drugs Product and Solutions
Table 33. Explicyte Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Explicyte Recent Developments and Future Plans
Table 35. Genscript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 36. Genscript Biotech Corporation Major Business
Table 37. Genscript Biotech Corporation Immune Cell Therapy Drugs Product and Solutions
Table 38. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Genscript Biotech Corporation Recent Developments and Future Plans
Table 40. HD Biosciences Company Information, Head Office, and Major Competitors
Table 41. HD Biosciences Major Business
Table 42. HD Biosciences Immune Cell Therapy Drugs Product and Solutions
Table 43. HD Biosciences Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. HD Biosciences Recent Developments and Future Plans
Table 45. Horizon Discovery Group Company Information, Head Office, and Major Competitors
Table 46. Horizon Discovery Group Major Business
Table 47. Horizon Discovery Group Immune Cell Therapy Drugs Product and Solutions
Table 48. Horizon Discovery Group Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Horizon Discovery Group Recent Developments and Future Plans
Table 50. ImmunXperts Company Information, Head Office, and Major Competitors
Table 51. ImmunXperts Major Business
Table 52. ImmunXperts Immune Cell Therapy Drugs Product and Solutions
Table 53. ImmunXperts Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ImmunXperts Recent Developments and Future Plans
Table 55. Molecular Imaging Company Information, Head Office, and Major Competitors
Table 56. Molecular Imaging Major Business
Table 57. Molecular Imaging Immune Cell Therapy Drugs Product and Solutions
Table 58. Molecular Imaging Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Molecular Imaging Recent Developments and Future Plans
Table 60. Promega Corporation,Personalis Company Information, Head Office, and Major Competitors
Table 61. Promega Corporation,Personalis Major Business
Table 62. Promega Corporation,Personalis Immune Cell Therapy Drugs Product and Solutions
Table 63. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Promega Corporation,Personalis Recent Developments and Future Plans
Table 65. STC Biologics Company Information, Head Office, and Major Competitors
Table 66. STC Biologics Major Business
Table 67. STC Biologics Immune Cell Therapy Drugs Product and Solutions
Table 68. STC Biologics Immune Cell Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. STC Biologics Recent Developments and Future Plans
Table 70. Global Immune Cell Therapy Drugs Revenue (USD Million) by Players (2018-2023)
Table 71. Global Immune Cell Therapy Drugs Revenue Share by Players (2018-2023)
Table 72. Breakdown of Immune Cell Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Immune Cell Therapy Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Immune Cell Therapy Drugs Players
Table 75. Immune Cell Therapy Drugs Market: Company Product Type Footprint
Table 76. Immune Cell Therapy Drugs Market: Company Product Application Footprint
Table 77. Immune Cell Therapy Drugs New Market Entrants and Barriers to Market Entry
Table 78. Immune Cell Therapy Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Immune Cell Therapy Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Immune Cell Therapy Drugs Consumption Value Share by Type (2018-2023)
Table 81. Global Immune Cell Therapy Drugs Consumption Value Forecast by Type (2024-2029)
Table 82. Global Immune Cell Therapy Drugs Consumption Value by Application (2018-2023)
Table 83. Global Immune Cell Therapy Drugs Consumption Value Forecast by Application (2024-2029)
Table 84. North America Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Immune Cell Therapy Drugs Raw Material
Table 115. Key Suppliers of Immune Cell Therapy Drugs Raw Materials
LIST OF FIGURES
Figure 1. Immune Cell Therapy Drugs Picture
Figure 2. Global Immune Cell Therapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immune Cell Therapy Drugs Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Immunomodulator
Figure 6. Other
Figure 7. Global Immune Cell Therapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Immune Cell Therapy Drugs Consumption Value Market Share by Application in 2022
Figure 9. Stomach Cancer Picture
Figure 10. lung Cancer Picture
Figure 11. Colorectal Cancer Picture
Figure 12. Esophageal Cancer Picture
Figure 13. Pancreatic Cancer Picture
Figure 14. Other Picture
Figure 15. Global Immune Cell Therapy Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Immune Cell Therapy Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Immune Cell Therapy Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Immune Cell Therapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Immune Cell Therapy Drugs Consumption Value Market Share by Region in 2022
Figure 20. North America Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Immune Cell Therapy Drugs Revenue Share by Players in 2022
Figure 26. Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Immune Cell Therapy Drugs Market Share in 2022
Figure 28. Global Top 6 Players Immune Cell Therapy Drugs Market Share in 2022
Figure 29. Global Immune Cell Therapy Drugs Consumption Value Share by Type (2018-2023)
Figure 30. Global Immune Cell Therapy Drugs Market Share Forecast by Type (2024-2029)
Figure 31. Global Immune Cell Therapy Drugs Consumption Value Share by Application (2018-2023)
Figure 32. Global Immune Cell Therapy Drugs Market Share Forecast by Application (2024-2029)
Figure 33. North America Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. France Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Immune Cell Therapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 50. China Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. India Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 67. Immune Cell Therapy Drugs Market Drivers
Figure 68. Immune Cell Therapy Drugs Market Restraints
Figure 69. Immune Cell Therapy Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Immune Cell Therapy Drugs in 2022
Figure 72. Manufacturing Process Analysis of Immune Cell Therapy Drugs
Figure 73. Immune Cell Therapy Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Immune Cell Therapy Drugs Picture
Figure 2. Global Immune Cell Therapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immune Cell Therapy Drugs Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Immunomodulator
Figure 6. Other
Figure 7. Global Immune Cell Therapy Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Immune Cell Therapy Drugs Consumption Value Market Share by Application in 2022
Figure 9. Stomach Cancer Picture
Figure 10. lung Cancer Picture
Figure 11. Colorectal Cancer Picture
Figure 12. Esophageal Cancer Picture
Figure 13. Pancreatic Cancer Picture
Figure 14. Other Picture
Figure 15. Global Immune Cell Therapy Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Immune Cell Therapy Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Immune Cell Therapy Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Immune Cell Therapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Immune Cell Therapy Drugs Consumption Value Market Share by Region in 2022
Figure 20. North America Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Immune Cell Therapy Drugs Revenue Share by Players in 2022
Figure 26. Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Immune Cell Therapy Drugs Market Share in 2022
Figure 28. Global Top 6 Players Immune Cell Therapy Drugs Market Share in 2022
Figure 29. Global Immune Cell Therapy Drugs Consumption Value Share by Type (2018-2023)
Figure 30. Global Immune Cell Therapy Drugs Market Share Forecast by Type (2024-2029)
Figure 31. Global Immune Cell Therapy Drugs Consumption Value Share by Application (2018-2023)
Figure 32. Global Immune Cell Therapy Drugs Market Share Forecast by Application (2024-2029)
Figure 33. North America Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. France Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Immune Cell Therapy Drugs Consumption Value Market Share by Region (2018-2029)
Figure 50. China Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. India Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Immune Cell Therapy Drugs Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Immune Cell Therapy Drugs Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Immune Cell Therapy Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Immune Cell Therapy Drugs Consumption Value (2018-2029) & (USD Million)
Figure 67. Immune Cell Therapy Drugs Market Drivers
Figure 68. Immune Cell Therapy Drugs Market Restraints
Figure 69. Immune Cell Therapy Drugs Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Immune Cell Therapy Drugs in 2022
Figure 72. Manufacturing Process Analysis of Immune Cell Therapy Drugs
Figure 73. Immune Cell Therapy Drugs Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
